Winner Medical
Winner Medical is the leading manufacturer for disposable wound-care and surgical products in China.
Winner Medical, founded in August 2000, is the Chinese manufacturer of disposable wound-care and surgical products focusing on manufacturing, R&D, and marketing cotton-based medical dressings and medical disposables, as well as consumer products under the "Purcotton" brand. The founder is Li Jianquan. Listed on the Shenzhen Stock Exchange in September 2020, the company's major shareholders include Winner Medical Group, Inc, Beijing Sequoia Xinyuan Equity Investment Center (L.P.), Shenzhen Kangsheng Investment Limited Partnership. Rivals with direct and indirect competition with Winner Medical are C&S Paper, Zhende Medical, Allmed Medical Products.
We-Linking Raised Over CNY 10 Mn in Angel Round
Intraoperative Neurophysiological Monitoring Equipment Developer NeuroFlag Closed An Angel Round
Surgerii Robotics: Single-Port Surgical Robots Poised to Transform Surgery
The worldwide surgical robotic market is expected to grow at a booming CAGR of 5.8% during 2022 to 2030, rising from USD 5.05 billion in 2022 to USD 21.41 billion in 2030. Of which, the single-port surgical robots that result in less pain, fewer scars, and quicker recovery, have tremendous up potential.
Mar 30, 2023 04:00 PM
ZD Medtech Raised Over CNY 100 Mn in Series B
Smart Powered Bionic Prosthetic Star BionicM Nets Over CNY 10 Mn
Medical Technology Company MacroLux Nets Nearly CNY 100 Mn in Series A
Robust medical: it plans to acquire the controlling equity of Hunan Ping An medical equipment
Mask protection unit rose in the afternoon
HastenPharma Secures USD 315 Mn in Financing to Focus on M&A Business and R&D
Anhui-based biopharmaceutical company HastenPharma(海森生物) raised USD 315 million in funding on April 20, with the financing round aimed at focusing on future mergers and acquisitions and product innovation, according to EqualOcean.
Apr 23, 2023 12:20 PM
Artificial Cardiac Company CoretechMed Raises Nearly CNY 200 Mn in Series C+
In the past five years, China's ventricular assist technology (i.e., "artificial heart") has developed rapidly, and three domestic implantable ventricular assist devices (LVADs) have been approved and marketed by the State Drug Administration, and another one is in the marketing declaration stage. The number of LVAD implantations has increased yearly, with a total of 363 LVAD implantations performed in 70 hospitals, a rapid increase.
Apr 17, 2023 05:12 PM
Imber: the shareholder Ruan bin has completed the reduction of 337500 shares and plans to continue to reduce no more than 1.32% of the shares
Robust medical: by the end of October, 1159400 shares had been repurchased
Global Leader in Radiosurgery Robots ZAP Sets Up China Headquarters in Suzhou
The China headquarters project of the ZAP-X photon surgery robot, led by ZAP, a global leader in the next-generation robotic surgical systems and a leading player in non-invasive brain surgery robots, has officially signed an agreement to settle in Suzhou.
Apr 13, 2023 04:06 PM
Clinical Microbiology Testing Company WillingMed Nets More than 100 Mn in Series B
WillingMed has independently developed and successfully reported and approved a series of automated testing instruments, software, testing reagents and other IVD products, and obtained intellectual property rights for more than 40 core technologies.
Apr 07, 2023 09:09 PM
Robust medical treatment: affected by the recent spread of delta virus strain, the company's demand for protective products such as masks and protective clothing has increased significantly
Xinxiang Chemical Fiber: some production workshops of viscose filament are temporarily shut down due to water inflow